Previous studies have reported the involvement of CCR5 in cardiac remodeling through the activation of immune responses.[41, 54] However, our findings suggest that CCR5 inhibitor MVC did not impact CF in our experimental model. The gene discussed is CCR5; the disease is cystic fibrosis.